1. |
世界卫生组织. 前十位死亡原因. 实况报道, 第310号, 2014. Available at: http://www.who.int/mediacentre/factsheets/fs310/zh/.
|
2. |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案). 中华哮喘杂志(电子版), 2013, 7(1): 1.
|
3. |
Miravitlles M, Jose Soler-Cataluna J, Calle MA, et al. Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Arch Bronconeumol, 2012, 48(7): 247-257.
|
4. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版). 中国医学前沿杂志(电子版), 2014, 6(2): 67-80.
|
5. |
Kankaanranta H, Harju T, Kilpeläinen M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines. Basic Clin Pharmacol Toxicol, 2015, 116(4): 291-307.
|
6. |
GOLD Executive Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2015). Available at: www.gold.com.
|
7. |
Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline. Chest, 2015, 147(4): 894-942.
|
8. |
GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2016). Available at: www.gold.com.
|
9. |
胡付品, 朱德妹, 汪复, 等. 2013 中国 CHINET 细菌耐药性监测. 中国感染与化疗杂志, 2014, 14(5): 365-374.
|